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a  b  s  t  r  a  c  t
N-nitroso  compounds  (NOCs)  may  represent  a  carcinogenic  risk  to  humans  following  endogenous  colonic
nitrosation  processes.  We  used  the  colon  adenocarcinoma  cell  line  Caco-2  to investigate  transcriptomic
changes  at  three  time  points  (1,  6, 24  h) following  exposure  to  genotoxic  concentrations  of six  different
NOCs  (two  nitrosamides,  four nitrosamines)  with  the  purpose  of  identifying  biological  processes  that  may
play  a part  in  the  carcinogenicity  of these  compounds.  This  is  especially  important  for  nitrosamide  expo-
sure where,  in  light  of  their  high  reactivity,  important  gene  expression  modifications  may  take  place  early
in the  exposure.  We  also  analyzed  NOC-induced  O6-methylguanine  adducts  in  relation  to  transcriptomics





Many  modified  pathways  appeared  related  to DNA damage,  cell  cycle,  apoptosis,  growth  factor  signaling
and differentiation,  which  are  linked  with  carcinogenicity.  Nitrosamides  showed  the strongest  response
at  1  h  of  exposure,  while  nitrosamines  had  the  strongest  effect  at 6 and  24  h. Additionally,  methylation
was  strongly  associated  with  processes  that  may  contribute  to  the  carcinogenic  risk.  In  summary,  we
have found  that  NOC-induced  gene  expression  changes  vary  over  time  and  that  many  of  the  modified
pathways  and  processes  indicate  a  carcinogenic  risk  associated  with  NOC  exposure.. Introduction
N-nitroso compounds (NOCs) have long been recognized as
enotoxic and carcinogenic agents in animal models and there-
ore may  also be implicated in human carcinogenesis (Lijinsky,
992). The gastro-intestinal tract seems to be a particularly rel-
vant target since NOCs are known to occur in certain types of
ood, such as beer, fish and nitrite-preserved meat (Tricker and
reussmann, 1991). More importantly, endogenous nitrosation of
OC precursors, particularly in the stomach and colon, can signif-cantly increase the colonic NOC exposure (Kuhnle and Bingham,
007; Mirvish, 1995). The endogenous formation of NOCs may
lso explain the link between meat consumption and colorectal
Abbreviations: CCR, colorectal cancer; GEO, Gene Expression Omnibus;
IF, macrophage migration inhibitory factor; MNNG, N-methyl-N’-nitro-N-
itrosoguanidine; MNU, N-methyl-N-nitrosurea; NDEA, N-nitrosodiethylamine;
DMA, N-nitrosodimethylamine; NOCs, N-nitroso compounds; NPIP, N-
itrosopiperidine; NPYR, N-nitrosopyrrolidine; O6-meG, O6-methylguanine;
CA, principal component analysis; TGF-, transforming growth factor beta.
∗ Corresponding author. Tel.: +31 43 3881088; fax: +31 43 3884146.
E-mail address: d.hebels@maastrichtuniversity.nl (D.G.A.J. Hebels).
378-4274/$ – see front matter ©  2011 Elsevier Ireland Ltd. All rights reserved.
oi:10.1016/j.toxlet.2011.09.012© 2011 Elsevier Ireland Ltd. All rights reserved.
cancer (CRC) risk since CRC incidence rates are correlated with
average meat consumption levels (Larsson and Wolk, 2006; Norat
et al., 2002) and meat consumption results in increased levels of
endogenous nitrosation (Kuhnle and Bingham, 2007). To investi-
gate the possible role of NOCs in human colon carcinogenesis, we
previously explored the transcriptomic effects of genotoxic NOC
concentrations following a 24 h exposure in the human colon ade-
nocarcinoma cell line Caco-2 (Hebels et al., 2009). We  distinguished
between two main classes of NOCs, nitrosamines and nitrosamides.
An interesting observation was the absence of strong gene expres-
sion effects following nitrosamide exposure. Since nitrosamides,
in contrast to nitrosamines, can decompose without the need for
metabolization to form genotoxic intermediates, particularly alky-
lating diazonium ion species, we hypothesize that modifications
in critical molecular processes may  occur earlier in the exposure
period. Furthermore, although the alkylating potential of NOCs
has been studied extensively and the role of alkylation in the
carcinogenic process is well documented (Hall and Montesano,
1990; Kaina et al., 2007; Shrivastav et al., 2010), it is of interest
to analyze gene expression changes associated with NOC-induced
alkylation over time. Alkylation of DNA, and methylation in par-
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xpression. For example, O6-methylguanine (O6-meG) has been
hown to both inhibit and promote the action of maintenance
ethylases on adjacent cytosine bases which is likely to result
n chromatin modifications that can influence the level of gene
ranscription (Hepburn et al., 1991; Tan and Li, 1990). In addi-
ion, O6-meG can inhibit transcription factor binding (Bonfanti
t al., 1991; Gray, 1995). Investigating methylation-associated gene
xpression changes could thus lead to the identification of criti-
al pathways which may  underlie the carcinogenic mechanism of
ction of methylating agents.
In order to establish time-dependent gene expression
esponses, we analyzed genome-wide gene expression in Caco-
 cells exposed at 1, 6 and 24 h to comparably genotoxic
oncentrations of 2 different nitrosamides (N-methyl-N′-
itro-N-nitrosoguanidine [MNNG] and N-methyl-N-nitrosurea
MNU]) and 4 nitrosamines (N-nitrosodiethylamine [NDEA], N-
itrosodimethylamine [NDMA], N-nitrosopiperidine [NPIP], and
-nitrosopyrrolidine [NPYR]). These NOCs can be formed in the
astro-intestinal tract (Sen et al., 2000; Tricker and Preussmann,
991) and induce malignant transformation of human colonic
pithelial cells (Paraskeva et al., 1990). We  identified cellular
rocesses that were modified over time by these NOCs, and
pplied separate per time point analysis to determine at what
ime points relevant pathways or cellular processes were most
trongly modulated. Individual gene expression data were linked
ith levels of apoptosis and cell cycle distribution as phenotypic
arkers of effect to functionally anchor gene sets differentially
odified by NOC exposure. To investigate the gene expression
odulations associated with methylation, we further explored the
ranscriptomic response of the three methylating NOCs (MNNG,
NU, and NDMA). To do this, we correlated gene expression levels
ith O6-meG adduct levels, one of the most frequently occurring
re-mutagenic DNA lesions found after exposure to methylating
gents (Kyrtopoulos, 1998), and analyzed the correlating gene set
or involvement in pathways or cellular processes. Our overall
oal is to establish a transcriptomic overview of NOC-induced and
ethylation-associated responses at a biological pathway level
ver time that can be used for further analysis on the carcinogenic
otential of these compounds.
. Materials and methods
.1. Cell culture
The human colon adenocarcinoma cell line Caco-2 was cultured in Dulbecco’s
odified Eagle’s Medium (Sigma–Aldrich, Zwijndrecht, The Netherlands) with
.5 g/L glucose, l-glutamine, NaHCO3 and pyridoxine HCl supplemented with 1%
v/v) nonessential amino acids, 1% Na-pyruvate, 1% penicillin/streptomycin and 10%
v/v) heat-inactivated foetal calf serum, all purchased from Gibco BRL (Breda, The
etherlands). Cell cultures were transferred weekly by trypsinization and incubated
t 37 ◦C in a humidified incubator containing 5% CO2.
.2. Treatment and isolation of cells
Caco-2 cells were treated with MNNG, MNU, NDEA, NDMA, NPIP or NPYR or the
orresponding solvent control (MilliQ or DMSO, final concentration 0.1%) at compa-
ably genotoxic concentrations, as established previously by comet assay analysis
Hebels et al., 2009). These concentrations were: MNNG (1 M),  MNU  (1 mM),  NDEA
50 mM),  NDMA (100 mM),  NPIP (40 mM)  and NPYR (100 mM). Exposures were car-
ied out in 25 or 75 cm2 culture flasks for 1, 6 or 24 h. All NOCs were obtained
rom Sigma–Aldrich (the respective product numbers and reported purity were:
5427LO [97%], N4766 [11% H2O, 3% acetic acid], N0756, N7756, N6007 [99.8%], and
58240 [98.9%]). Experiments were carried out in duplicate. Cells were isolated by
rypsinization and washed in PBS and subsequently stored at −20 ◦C (for methyla-
ion assay) or fixed in methanol and stored at −20 ◦C (for flow cytometry). Cells for
icroarray experiments were isolated with TRIzol® Reagent (Invitrogen, Breda, The
etherlands) and stored at −20 ◦C. Viability of cells was determined with the MTT
est  in ELISA plates (Greiner Bio-One, Alphen a/d Rijn, The Netherlands) as described
y  Mosmann (1983). All exposures resulted in >90% viability.tters 207 (2011) 232– 241 233
2.3. Immunocytochemistry and flow cytometric analysis
Methanol-fixed cells were indirectly stained for cleaved cytokeratin 18 (an early
sign of apoptosis) using the primary antibody M30 CytoDeath (Roche, Penzberg,
Germany) and subsequently analyzed by flow cytometric analysis using a FAC-
Sort (Becton Dickinson, Sunnyvale, USA) as described by Schutte et al. (2006).  Data
analysis was  performed as described previously (Hebels et al., 2009).
2.4. Determination of O6-meG in DNA by ELISA
Levels of O6-meG were determined in DNA isolated from NOC-exposed Caco-2
cells using a newly developed ELISA method as recently described by Georgiadis et al.
(2011).  DNA samples were analyzed in triplicate. For the quantitation of O6-meG in
unknown DNA samples, a standard curve consisting of DNA standards with known
O6-meG content was constructed with each microwell plate. These standards were
prepared by mixing HeLa DNA, methylated with MNU  and accurately analyzed by
HPLC (O6-meG content: 1 adduct/13,000 nucleotides), with unmodified HeLa DNA
extracted from O6-meG-DNA methyltransferase-overexpressing cells as described
previously (Georgiadis et al., 2000).
2.5. Microarray hybridization and data analysis
Microarray hybridization was performed as described previously (Hebels et al.,
2009).  In short, RNA was  isolated from QIAzol® suspended cells, following a 1,
6  or 24 h exposure to comparably genotoxic NOC concentrations (two biological
replicates) and dye-labeled cRNA (Cy3 or Cy5) was synthesized. Samples were
hybridized on Agilent 4 × 44 K Whole Human Genome microarrays (Agilent Tech-
nologies, Amstelveen, The Netherlands) against their vehicle control, applying a
dye-swap between the biological replicates.
After scanning the microarray slides, using settings described before (Hebels
et al., 2009), the data was  flagged manually and automatically using the GenePix
Pro software (version 6.0, Molecular Devices, Sunnyvale, CA). Following a quality
control in the statistical software environment R (version 2.10.1, The R Foundation
for Statistical Computing, Vienna, Austria), regions of lower quality were identified
and  subsequently flagged in Spotfire DecisionSite (version 9.1, TIBCO, Somerville,
MA). LOWESS normalization and subsequent data analysis was performed in Array-
Track (version 3.4, NCTR, Jefferson, AR). The expression difference for each spot was
calculated by subtracting the log 2 transformed mean intensity of the control sam-
ple  from the log 2 transformed mean intensity of the treated sample resulting in a
log 2 ratio.
Differentially expressed genes were selected by using a combined filtering on
significance level and log 2 ratio as proposed by Shi et al. (2006).  ArrayTrack was
used  to select differentially expressed genes based on a two-tailed Student’s t-test
(p-value < 0.05), with a minimum absolute log 2 ratio of 0.5 for each compound and
time point (false discovery rates were all below 20%). These genes were subsequently
imported in MetaCoreTM (GeneGo, San Diego, CA). MetaCoreTM is an online software
suite that identifies and visualizes the involvement of differentially expressed genes
in specific cellular pathways, which is subsequently related to the total number of
genes involved in the particular pathway and in all the available pathways combined.
This results in a set of significantly modulated pathways (p-value < 0.05).
The online software suite GenePattern version 3.1
(http://www.broad.mit.edu/cancer/software/genepattern/) was  used for prin-
cipal component analysis (PCA) of the tested compounds. PCA plots were generated
in  GenePattern by reducing the data to two dimensions and visualized in Microsoft
Excel. Time–course effects were further investigated, by ANOVA analysis in Array-
Track to determine which genes changed their expression profile significantly over
time. These genes were also analyzed in MetaCore to determine their involvement
in  pathways.
Gene expression data were subsequently used to perform Spearman’s rank
correlation analyses with levels of apoptosis, cell cycle phase distribution,
and  O6-meG levels using the online Gene Expression Profile Analysis Suite
(http://gepas.bioinfo.cipf.es/). Significantly correlating genes (p-value < 0.05) were
subsequently further analyzed in MetaCore.
The gene expression data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus (GEO) and are available
through GEO series accession number GSE20993 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE20993).
3. Results
3.1. Time–course analysis: PCA and ANOVA
In order to investigate the transcriptomic effects of NOCs over
time we performed whole genome microarray analysis at three
time points for each of the six selected NOC, and PCA plots were
generated to visualize the differences in gene expression profiles.
The three non-methylating NOCs (NDEA, NPIP, and NPYR) show
a similar response compared to each other, and simultaneously
234 D.G.A.J. Hebels et al. / Toxicology Letters 207 (2011) 232– 241














































Fig. 1. PCA plot based on genes present for all NOCs at three time points. Th
emonstrate a time-dependent development of the gene expres-
ion response (Fig. 1). Although NDMA is closely associated with
hese nitrosamines at 6 h of exposure, it shows a different response
fter 24 h, which we also found in our previous study (Hebels et al.,
009). To look at each individual time point in more detail, PCA
lots were also generated per time point (Suppl. Figs. A.1–A.3).
hile these plots show a similar pattern as Fig. 1, they also reveal
hat MNU  and MNNG respond differently at each time point. In
ccordance with the number of significantly modulated genes and
athways, MNU  develops the most differentiating response at 1 h of
xposure, while MNNG generates such a response at 6 h. After 24 h
f exposure both nitrosamides are grouped closely to the origin of
he plot indicating little effect.
The time–course development of the gene expression profile
as further investigated using an ANOVA analysis to determine
hich cellular processes contribute most to the changes in expres-
ion profile over time. In Table 1, an overview of processes for
ach of the six compounds found by MetaCore analysis is pre-
ented. In Suppl. Table A.1, a more comprehensive overview can
e found which includes the names of the GeneGO pathways mod-
fied in each of the cellular processes. Amino acid metabolism,
poptosis and survival, and cystic fibrosis are significantly modi-
ed over time by all compounds, except MNU. The development,
-protein signaling, and immune response processes are modified
y all six compounds and are likely to play an important part in the
ime–course development of the gene expression profile, especially
ince the number of pathways involved in these processes is, over-
ll, relatively high. Other strongly modified processes comprise cell
ycle, steroid metabolism, and transcription. When comparing the
itrosamide and nitrosamine-induced time-dependent changes, in
eneral, more processes and pathways seem to be modified over
ime during nitrosamine exposure. The percentages of involved
enes are also higher for the nitrosamine group, which is in agree-
ent with the PCA plots. The Venn diagram in Fig. 2A shows the
verlap between the two nitrosamides and the nitrosamines as
 group. MNNG and MNU  uniquely change the expression of a
onsiderable number of pathways over time. For MNNG these path-
ays are mainly involved in apoptosis and survival, glutathione
etabolism, G-protein signaling and immune response, while for
NU  cell cycle, development, and DNA damage responses are
ainly affected (Suppl. Table A.2). The pathways uniquely mod-
fied by the nitrosamines are involved in similar processes but
ften regulate different parts of the process. For example, the apo-
tosis and survival pathways include different signaling cascades
nd several development pathways are involved in transforming
rowth factor beta (TGF-)  signaling. There are also a number of
Fig. 2. Venn diagrams showing the number of overlapping ANOVA pathways
between MNNG, MNU, and the nitrosamines as a group (A) and between the four
individual nitrosamines (B).
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Table  1
MetaCore analysis of ANOVA data resulting in the identification of cellular processes modified over time for each NOC following exposure at genotoxic concentrations.
Cellular process MNNG MNU NDMA NDEA NPIP NPYR
Amino acid metabolism 5(30) 2(48) 4(56) 1(56) 5(78)
Apoptosis and survival 3(26) 12(52) 5(44) 3(48) 8(63)
Butanoate metabolism 1(55)
Cell adhesion 2(62)
Cell  cycle 1(25) 11(38) 8(55) 1(50) 7(68)
Cystic  fibrosis 1(26) 1(65) 1(53) 4(68) 2(69)
Cytoskeleton remodeling 1(20) 2(52)
Development 2(26) 9(28) 13(49) 2(49) 7(48) 3(61)
DNA  damage 1(24) 3(34) 5(54) 1(46)
Folic  acid metabolism 1(60)
Fructose metabolism 2(26) 2(49)
Galactose metabolism 2(59) 1(69)
Glutathione metabolism and oxidative stress 3(21) 1(67) 1(78)
Glycolysis and gluconeogenesis 1(60) 1(53) 2(57) 1(67)
G-protein signaling 2(49) 1(36) 2(52) 1(50) 1(56) 2(65)
Heme  metabolism 1(48)
Immune response 10(31) 6(31) 4(55) 3(58) 7(54) 1(67)
Neurodisease 1(72)
Neurophysiological process 1(58) 1(58)
N-glycan biosynthesis 1(47)
Nucleotide metabolism 2(53) 2(53)
Oxidative phosphorylation 1(37) 1(46) 1(54)
Propionate metabolism 1(62)
Proteolysis 1(58) 1(86)
Regulation of lipid metabolism 1(3) 1(67) 1(67) 1(65)
Reproduction 1(21)
Signal transduction 1(26) 1(48) 1(59)
Steroid metabolism 1(29) 2(56) 3(57) 2(68) 2(69)
Sulfur  metabolism 1(39) 1(50) 1(56)
Transcription 1(23) 1(26) 3(50) 3(55) 2(67)
Transport 1(20) 1(42) 2(66)
Tricarboxylic acid cycle 1(56)
Ubiquinone metabolism 1(46) 1(64)































alues represent the number of significantly modified pathways for each cellular 
hree  time points in these pathways. Absence of a value means that the cellular pro
athways involved in processes not modified by nitrosamides, such
s nucleotide metabolism and several other metabolic pathways.
he Venn diagram in Fig. 2B shows that within the nitrosamine
roup, a total of 35 pathways are uniquely modified by NDMA,
hich includes a number of pathways involved in apoptosis and
urvival, cell cycle regulation, development, and DNA damage
Suppl. Table A.3).
.2. Transcriptomic analysis per time point
To investigate transcriptomic changes per time point for each
ompound, significantly modulated genes (p-value < 0.05) with a
inimum absolute log 2 ratio of 0.5 were selected and subsequently
sed for a pathway analysis in MetaCore. An overview of the cellu-
ar processes modified by each of the six compounds per time point
nd a more comprehensive overview, which includes the names of
he GeneGO pathways modified in each of the cellular processes,
s presented in Suppl. Tables A.4–A.7.  The percentage of signifi-
antly modulated genes in each of the pathways and the average
er process is also presented there. A total of 39 cellular processes
as found to be modified by at least one of the compounds and for
ost processes the percentage of involved genes for the associated
athways increases with time. Some of the processes most strongly
epresented include apoptosis and survival, cell cycle, cytoskele-
on remodeling, development, DNA damage, G-protein signaling,
mmune response, regulation of lipid metabolism, and transcrip-
ion. Although some cellular processes are significantly modulated
y the same compound at all three time points, most only come up
nce or twice. The development and immune response processes
re present at every time point for nearly every compound. Cell
ycle and DNA damage processes, on the other hand, are mostlys followed by the average percentage of significantly modulated genes across the
as not differentially modified over time for that particular compound.
modified at 6 h. To visualize the changes over time, the total num-
ber of pathways per condition for all processes combined is shown
in Fig. 3, with the total average of involved genes. The percent-
age of involved genes stays relatively constant over time for the
nitrosamides. The number of pathways, however, is highest at 1 h
of exposure for both nitrosamides and MNU  even shows the high-
est number of pathways of all NOC across all time points. Although
the nitrosamines modulate different numbers of pathways across
time and also influence many pathways at 1 h, the average percent-
age of genes involved in these pathways is highest at 6 and 24 h.
Overall, the nitrosamides appear to induce the strongest response
at 1 h, while the nitrosamines tend to have the most pronounced
effects at later time points.
3.3. Apoptosis and cell cycle distribution correlation analyses
We  subsequently associated gene expression data from all time
points and compounds with levels of apoptosis and cell cycle dis-
tribution as phenotypic markers of effect to functionally anchor
gene sets differentially modified by NOC exposure over time. Lev-
els of apoptosis and effects on cell cycle distribution are shown
in Fig. 4A and B, respectively. The nitrosamines show a time-
dependent increase in the level of apoptosis, although this increase
is only significantly different from control conditions at the 24 h
nitrosamine exposure. Cell cycle distribution after 24 h of expo-
sure was significantly affected by all compounds, except MNNG.
At earlier time points, no effects were observed compared to con-
trol distribution. MNU, NDEA, NPIP, and NPYR exposure resulted in
an S-phase accumulation of cells, which for MNU, NPIP, and NPYR
was also associated with a decrease in G1-phase cells, while NDEA
shows a concomitant decrease in G2-phase cells. NDMA  exposure









ig. 3. Time–course dependent effect of NOC exposure on the number of significa
ignificantly modulated genes involved in these pathways per condition (between 
esults in a G1-phase accumulation of cells and a decreased S-phase
istribution.
Genes significantly correlating with the level of apoptosis or
ell cycle phase distribution (p-value < 0.05) across all time points
ig. 4. Flow cytometric analysis of (A) the level of apoptosis in Caco-2 cells exposed to ge
4  h of exposure. At 1 and 6 h, cell cycle distribution was  not significantly different from 
ndicate standard deviation. Student’s t-test versus control: *p-value < 0.05; **p-value < 0.odulated GeneGO pathway maps (p-value < 0.05) and the average percentage of
ts).
and compounds were used for a pathway analysis in MetaCore.
As shown in Table 2, these genes are indeed involved in apoptosis
and cell cycle related cellular processes. A complete overview of
correlating processes can be found in Suppl. Table A.8.
notoxic concentrations of six NOCs for 1, 6 or 24 h and (B) cell cycle distribution at
control. DMSO control is not shown but was  identical to normal control. Error bars
01.
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Table  2
Selection of cellular processes correlated with apoptosis and cell cycle phase distribution as found by MetaCore analysis.
Phenotypical marker Cellular process
Apoptosis and survival Cell adhesion Cell cycle Cytoskeleton remodeling Nucleotide metabolism Proteolysis
Apoptosis 7(67) 3(68) 2(68) 2(66) 5(68) 2(72)
G1-phase 1(50) 1(33)
S-phase 1(27) 1(17)




































alues represent the number of significantly modified pathways for each cellular 
hree  time points and six compounds in these pathways.
.4. O6-meG correlation analysis
To investigate which gene expression modifications are asso-
iated with the methylating properties of NOCs, we performed a
orrelation analysis considering effects of the three methylating
OCs. O6-meG adducts were measured by HPLC analysis, which
evealed a time-dependent decrease in the number of adducts for
ll three compounds, although NDMA seems to reach a steady-state
evel between 6 and 24 h (Fig. 5).
Genes found to significantly correlate (p-value < 0.05) with O6-
eG adducts induced by MNNG, MNU, and NDMA across all time
oints were analyzed in MetaCore to identify which pathways and
rocesses were most strongly associated with methylation levels.
rocesses correlated with the level of O6-meG adducts are pre-
ented in Table 3, which includes several apoptosis and survival,
ell cycle regulation, cytoskeleton remodeling, and DNA damage
elated pathways. Other strongly modified processes are involved
n development, immune response, G-protein signaling, regula-
ion of lipid metabolism, and transcription. The average percentage
f genes in these pathways is relatively high, indicating a strong
nvolvement with the methylating damage induced by these com-
ounds. A complete overview of all the pathways involved in these
rocesses can be found in Suppl. Table A.9.
. Discussion
In this study, we investigated NOC-induced gene expression
hanges at multiple time points in order to identify genes and cellu-
ar processes that may  change over time, or that might be missed if
ust one time point is investigated. We  hypothesize that in view of
heir high reactivity nitrosamides induce important gene expres-
ion changes relatively early after exposure. These gene expression
hanges are linked to induced levels of alkylating DNA-damage to
able 3
ellular processes correlated with O6-meG levels in DNA as found by MetaCore
nalysis.
Cellular process Correlating pathways















alues represent the number of significantly modified pathways for each cellular
rocess followed by the average percentage of significantly modulated genes in
hese  pathways.s followed by the average percentage of significantly modulated genes across the
understand the relevance this type of DNA damage in the carcino-
genicity of NOC.
4.1. Nitrosamide-induced gene expression response
In the PCA plots (Fig. 1 and Suppl. Figs. A.1–A.3)  the nitrosamides
shift position over time and always group separately from the
nitrosamines with MNNG and MNU  uniquely changing the expres-
sion of many pathways over time as compared to the nitrosamines
(Fig. 2A and Suppl. Tables A.1 and A.2). Although the total average
percentage of significantly modulated genes stays relatively con-
stant over time for both nitrosamides (Suppl. Table A.5 and Fig.
A.3), the genes modulated after 1 h of exposure are involved in a
higher number of pathways which demonstrates the importance of
interpreting data at a functional level. As demonstrated by Fig. 2A
and the affected cellular processes per time point (Suppl. Tables
A.4–A.7),  MNNG and MNU  have different transcriptomic effects.
Modifications in cell cycle pathways, for example, are observed
after 1 h of MNU  exposure, whereas MNNG exposure does not seem
to affect the progression of the cell cycle at all. Induction of methyl
adducts in DNA by MNU  after 1 h is significantly higher than for
MNNG (Fig. 5), which could explain the absence of a cell cycle
block following MNNG exposure. In addition, MNU  and MNNG
induce different protein adducts, either through carbamoylation
(MNU) or guanidinylation (MNNG), and histones are known tar-
gets for methylation which could differently influence the gene
expression profile (Pinsky et al., 1980). Nuclear protein methyla-
tion is also known to be induced by alkylating agents (Boffa and
Bolognesi, 1985; Boffa et al., 1987) and the level of MNNG-induced
methylation (protein or DNA) is determined by intracellular thiol
concentrations which could all play an important part in the tran-
scriptomic changes (Jensen and Magee, 1981). It is also interesting
that carcinogenic methylating agents methylate proteins in a differ-
ent pattern than non-carcinogenic methylating agents (Boffa and
Bolognesi, 1985). Modifications in apoptosis and cell cycle regula-
tion pathways for MNNG and MNU  exposure respectively, are in
agreement with flow cytometry data showing a significantly dif-
ferent MNU-induced cell cycle phase distribution at 24 h, whereas
MNNG shows a (non-significant) peak in apoptosis at 6 h (Fig. 4A
and B). Other modified processes that contribute strongly to the
transcriptomic time–course development include development,
DNA damage, G-protein signaling, immune response and transcrip-
tion and as shown by the per time point analysis (Table 1 and Suppl.
Tables A.4–A.7), these modifications appear to take place early in
the exposure.
Both nitrosamides also modulate a considerable number of
pathways involved in developmental processes that regulate cell
growth and proliferation, such as the WNT  signaling pathway
and growth factor/hormone regulated pathways (Suppl. Tables
A.4–A.7). These types of modifications are especially interesting
for the nitrosamides as the carcinogenicity of these compounds is
usually attributed to their DNA damaging capability. Alterations
in WNT  signaling and growth regulation play an important role
in colorectal carcinogenesis (de Lau et al., 2007; Terzic et al., 2010)












































ig. 5. Level of O6-meG in DNA from Caco-2 cells following exposure to genotoxic c
nd could contribute to cancer development. Additionally, immune
esponse pathways are strongly affected (Table 1 and Suppl. Tables
.4–A.7), including several interleukin and macrophage migra-
ion inhibitory factor (MIF) signaling pathways. Nitrosamides have
een reported to have immunosuppressive effects (Schoental and
ensted, 1989) and intestinal epithelial cells, including the Caco-2
ell line, excrete pro-inflammatory cytokines and express cytokine
eceptors (Varilek et al., 1994; Vitkus et al., 1998). Interleukin-6, for
xample, plays an important role in the induction of the acute phase
esponse and the intestinal inflammatory response (Akira et al.,
993) and also has immunosuppressive properties (Hegde et al.,
004), while MIF  is associated with colorectal cancer development
He et al., 2009).
.2. Nitrosamine-induced gene expression responses
The nitrosamines form a separate group in the PCA plot, espe-
ially at the 6 and 24 h time points (Fig. 1), although NDMA shows
 deviating response at 24 h. Based on the changes in the per-
entage of genes and the number of pathways over time (Fig. 3),
he strongest response seems to occur after 6 h, although NDMA
nd NPIP form an exception concerning the number of pathways.
ne hour of exposure already affects many pathways, although the
verage percentage of involved genes is considerably lower than
t 6 or 24 h. The deviating response of NDMA is most likely due to
he 35 uniquely modified pathways found in the ANOVA analysis,
hich are involved in processes like apoptosis and survival, cell
ycle, development, and DNA damage (Fig. 2B and Suppl. Tables
.1 and A.3). These specific processes suggest that the type of DNA
amage induced by NDMA plays a role in its response. NDMA-
nduced methyl adducts are different from the larger alkyl adducts
nduced by the other nitrosamines, and more efficiently repaired by
6-methylguanine-DNA methyltransferase. This repair activity can
e expected to influence cell cycle blockage and apoptosis (Kaina
t al., 2007), and compared to the other nitrosamines, NDMA indeed
howed the smallest increase in apoptosis and a different cell cycle
lockage effect (Fig. 4A and B).
A large number of pathways involved in development are
egulated at every time point by the nitrosamines, where
itrosamide-induced modifications are limited to the 1 h expo-
ure. The response seems to be strongest after 6 and 24 h since
he percentage of involved genes is highest at these time points
Fig. 3). Many of these pathways are differentially regulated
ver time (Table 1) and include several pathways involved in
rowth factor signaling and differentiation, such as TGF- and the
NT and Notch signaling pathways (Suppl. Table A.1). From atrations of MNNG, MNU or NDMA. Values are corrected for background levels.
carcinogenesis perspective, this could be very important as
modifications in these pathways could influence the level of dif-
ferentiation and cell division in the colonic epithelium. The WNT
and Notch signaling pathways, for example, are known to interact
in the maintenance of progenitor cell populations in the colon (de
Lau et al., 2007). It seems that both nitrosamines and nitrosamides
are capable of modifying essential developmental processes, which
could work in concert with the DNA damaging capabilities of NOCs
in the carcinogenic process.
Nitrosamine exposure also strongly affects the immune
response as demonstrated by the large number of pathways
involved in this process (Table 1 and Suppl. Tables A.1 and
A.4–A.7). Although the nitrosamides also affected the immune
response throughout the exposure period, the nitrosamine-
induced response is much stronger, especially at 6 and 24 h, with
more involved pathways and a higher percentage of modulated
genes. Nitrosamines have immunosuppressive effects (Haggerty
and Holsapple, 1990) and this may  influence the innate immune
response of colonic epithelial cells. Since the immune response
also plays an important role in the development of colon cancer,
especially in the promotion phase of the carcinogenic process, this
indicates an additional way  for nitrosamines to influence colon can-
cer risk (Terzic et al., 2010). As shown in Suppl. Tables A.5–A.7,
several cytokine signaling pathways, such as MIF  and interleukin-1,
6, 12, 22 and 27 signaling are modified, many of which are impli-
cated in colon cancer development (He et al., 2009; Terzic et al.,
2010). The four nitrosamines do not always affect the same path-
ways and the net effect on immune modulation may  not always
be the same for all nitrosamines. Nevertheless, the PCA plots imply
that especially NDEA, NPIP, and NPYR induce a similar response.
Our findings demonstrate the relevance of further research into
the immunomodulatory properties of NOCs.
Other interesting observations are the modifications in path-
ways involved in regulation of lipid metabolism, cystic fibrosis,
and steroid metabolism which are regulated at all time points,
although not for every nitrosamine (Suppl. Tables A.5–A.7). Lipid
metabolism regulation could be associated with the apoptotic
process (Zhou et al., 2003), but it may  also play a part in the cys-
tic fibrosis process. The pathways belonging to this process are
involved in ion channel conductance regulation and lipid synthe-
sis and transportation and are known to play a very important
role in intestinal fluid and ion concentration regulation (Mailhot
et al., 2009). The steroid metabolism pathways could be explained
in the context of nitrosamine metabolism which is known to
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.3. Phenotypic anchoring of apoptosis and cell cycle effects
The ANOVA and time point analyses of NOC-induced gene
xpression modifications confirm the changes in levels of apopto-
is and cell cycle distribution found by flow cytometry for both the
itrosamides and nitrosamines which already shows that a time
eries analysis of transcriptomic data can reflect the phenotypic
ffects of NOC exposure. The association between the flow cytom-
try results and the apoptosis and cell cycle regulation processes
s further confirmed by a correlation analysis (Table 2, Suppl. Table
.8), which shows that genes significantly correlating with apopto-
is or cell cycle phase distribution are, in turn, involved in these very
ame processes and closely related processes like cell adhesion,
ytoskeleton remodeling, nucleotide metabolism, and proteolysis.
.4. Methylation-related gene expression modulations
Since there are indications that methylating damage may  influ-
nce the gene expression response, this could contribute to the
arcinogenic effect associated with this type of damage. Guanine
ethyl adducts, and possibly others, can influence transcrip-
ion factor binding and the action of maintenance methylases
n adjacent cytosine bases, which could both have important
onsequences for gene expression modifications in relation to car-
inogenesis (Bonfanti et al., 1991; Gray, 1995; Hepburn et al., 1991;
an and Li, 1990).
The analysis of O6-meG levels shows that NDMA induces a rel-
tively low level of methylation compared to the nitrosamides
hich is somewhat surprising, especially since the concentra-
ion of NDMA used in this study is much higher than for the
itrosamides. Animal studies have shown that NDMA is by far the
ost efficient agent capable of generating O6-meG in blood cell
NA when compared with other known methylating agents, such
s MNU  (Souliotis et al., 1995; Valavanis et al., 1994). However,
his does not seem to be true for Caco-2 cells since we found MNU
o be the most efficient methylating agent, while MNNG gener-
ted methyl adducts at approximately the same level as NDMA
Fig. 5). Since the alkylating properties of nitrosamines are depen-
ent on their metabolic activation by CYP450, this will influence
he formation of O6-meG adducts. Although Caco-2 cells and the
uman colon are both known to express CYP enzymes involved in
itrosamine metabolism (Bergheim et al., 2005; Borlak and Zwadlo,
003), this is lower than in, for example, liver tissue. A com-
ination of the CYP450-dependent biotransformation and higher
tability of nitrosamines allows for a longer continuous exposure
hich is likely to influence gene expression more extensively and
xplain the transcriptomic difference between nitrosamines and
itrosamides found in this study. The decrease in O6-meG adducts
ollowing NDMA exposure indeed levels out between 6 and 24 h
uggesting a continuous formation of reactive diazonium ions,
hereas both nitrosamides show an incessant decrease over time.
A correlation analysis of transcriptomics results across all time
oints reveals a number of processes that are associated with
ethylation induced by MNNG, MNU, and NDMA (Table 3). Apo-
tosis and survival, cell cycle regulation and related processes,
uch as cytoskeleton remodeling and nucleotide metabolism, are
nvolved and would also be expected to be associated with methy-
ation levels, since this type of damage is a well-known inducer
f apoptosis accompanied by cell cycle blockage and cytoskele-
on modifications (Kaina et al., 2007). DNA damage pathways are
ssociated with methylation levels as well. The results also suggest
hat methylation levels influence development, G-protein signal-
ng and the immune response, since many pathways are involved
n these processes. Especially development is strongly represented
nd includes many pathways involved in growth factor signaling
ften involving the JAK-STAT cascade, while the G-protein signalingtters 207 (2011) 232– 241 239
process includes a number of RAS signaling pathways (Suppl. Table
A.9). These pathways are implicated in the carcinogenic process and
it is possible that the modifications in these pathways represent an
epigenetic component of methylation-associated gene expression
changes, thereby providing a way to influence crucial carcinogenic
mechanisms in parallel to the genotoxic mode of action (Smirnova
et al., 2007; Takayama et al., 2006; Wu  et al., 2010). Whether
other types of alkylation, such as adducts induced by NDEA, NPIP,
and NPYR, are also linked to gene expression modifications is not
known, but would be worth investigating.
It is an interesting observation that MNU, which causes the high-
est O6-meG levels after 1 h of exposure, also affects the highest
number of pathways at this time point (Fig. 3). In general, the time-
dependent decrease in methylation level induced by these three
investigated compounds is paralleled by a decrease in the num-
ber of significantly modulated pathways. Although the processes
found in the correlation analysis were also found in the ANOVA
and per time point analyses, the pathways involved in each of
the processes are not always the same or not that strongly repre-
sented for the individual compounds in the time point analysis (see
Suppl. Tables A.1 and A.5–A.7).  Especially the nitrosamides are not
strongly involved in some of the processes found in the correlation
analyses, such as the apoptosis and DNA repair processes. This may
be a result of the filtering criterion used in the time point analysis,
whereas the correlation analyses uses all significantly correlating
genes regardless of log 2 ratio or p-value per time point. The path-
ways found in the correlation analyses, which combines all time
points in the analysis, therefore probably represent a more subtle
effect that is difficult to pick up per time point.
4.5. Correspondence to in vivo situation
Interpretation of the transcriptomic results in terms of in vivo
CRC risk following exposure to NOCs should be done with consid-
erable restraints. Aside from the obvious limitation of comparing a
cell line model to an in vivo organ, the concentrations used in this
study are also rather high as compared to what is normally found
in the colon. In vivo NOC exposures as a result of endogenous nitro-
sation can reach micromolar levels in the colon lumen (Lunn et al.,
2007), which is considerably lower than the millimolar concentra-
tions of nitrosamines that were used in this study. Although the
applied nitrosamide concentrations are in the micromolar range,
reliable data on nitrosamide concentrations in the colon lumen are
lacking, making it difficult to make a good in vivo–in vitro com-
parison. In addition, in vivo exposures occur over a much longer
time frame at varying concentrations, which could also result in
different effects. In this context it is, however, reassuring that we
recently identified transcriptomic responses that correlate with
in vivo NOC exposure and that match some of our results here.
These responses include modifications in pathways related to the
DNA damage response, apoptosis and survival, and the immune
response (Hebels et al., 2011a,b). This indicates that the in vitro
results found here can indeed provide valuable insights into the
toxicological properties of NOCs using transcriptomics.
4.6. Conclusions
In summary, we  have found that NOC-induced gene expres-
sion changes vary over time and that nitrosamides induce the
strongest response within 1 h after onset of the exposure. Many of
the pathways and processes modified may  indicate a carcinogenic
risk associated with NOC exposure since they involve pathways
implicated in crucial developmental signaling cascades. Methy-
lation is also associated with processes that could contribute to
the carcinogenic risk following colonic NOC  exposure, suggesting
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rocess through gene expression modulations. Further research is
eeded to determine if these modifications also play a role in cancer
evelopment in the human colon, preferably in an in vivo setting
ocusing on endogenous nitrosation processes. This would over-
ome some of the limitations of this study, such as the rather high
xposure concentrations compared to what can be expected in vivo
nd the relative simplicity of a cell line compared to much more
omplex colon tissue. Nevertheless, the temporal transcriptomic
esponses discovered here give a more detailed overview of the
ossible mechanisms of action of NOCs and provide new topics of
esearch into the carcinogenic properties of these compounds in
umans.
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